Your session is about to expire
← Back to Search
supported group for Post Thoracotomy Pain Syndrome (POVA Trial)
N/A
Waitlist Available
Research Sponsored by Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* Any patient in whom the management of a bronchopulmonary cancer, or his strong suspicion, justifies a bilobectomy, a lobectomy or a segmentectomy by videothoracoscopy.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the recovery unit to post-operative day 2
Awards & highlights
No Placebo-Only Group
Summary
The investigators want to be able to show a 66% decrease in the incidence of shoulder pain in the "support" group compared to the "suspension" group.
Eligible Conditions
- Post Thoracotomy Pain Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from the recovery unit to post-operative day 2
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the recovery unit to post-operative day 2
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
post thoracoscopy shoulder pain measured on the Visual Pain Scale
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: supported groupExperimental Treatment1 Intervention
Arm on the operated side at 0 ° abduction, 90 ° anti-pulsation, resting on an adjustable support arm support located opposite the patient's head.
Group II: suspension groupActive Control1 Intervention
Arm on the side operated at 90 ° abduction, 90 ° anti-drive, resting on an arm support.
Find a Location
Who is running the clinical trial?
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecLead Sponsor
36 Previous Clinical Trials
9,601 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger